Vikram Iyer1, Sophie Rowbotham2, Erik Biros3, John Bingley4, Jonathan Golledge5. 1. School of Medicine, University of Queensland, Herston, QLD 4029, Australia; Department of Vascular and Endovascular Surgery, Townsville Hospital, Douglas, QLD 4814, Australia; Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Douglas, QLD 4814, Australia. 2. School of Medicine, University of Queensland, Herston, QLD 4029, Australia; Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Douglas, QLD 4814, Australia. 3. Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Douglas, QLD 4814, Australia. 4. School of Medicine, University of Queensland, Herston, QLD 4029, Australia. 5. School of Medicine, University of Queensland, Herston, QLD 4029, Australia; Department of Vascular and Endovascular Surgery, Townsville Hospital, Douglas, QLD 4814, Australia; Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Douglas, QLD 4814, Australia. Electronic address: jonathan.golledge@jcu.edu.au.
Abstract
BACKGROUND AND AIMS: There is increasing interest in identifying novel methods for abdominal aortic aneurysm (AAA) diagnosis. Non-coding RNA molecules such as microRNAs (miRNAs) are stable within the circulation and may serve as biomarkers for AAA. This systematic review aimed to identify miRNAs associated with a diagnosis of human AAA based on currently published original research. METHODS: A systematic search of the MEDLINE and EMBASE databases identified studies assessing miRNA expression in abdominal aortic tissue or circulating blood from human AAA cases compared to non-aneurysmal controls. Data from included studies were extracted to assess methods and results after independent quality assessment by two reviewers. RESULTS: 15 studies were included in this review. 11 studies obtained aortic tissue samples from 195 AAA cases and 104 controls with normal aortas. Nine studies obtained circulating blood samples from 526 AAA cases and 441 controls. miR-21 was differentially expressed in AAA tissue in five separate studies, with four studies reporting upregulation and one reporting downregulation. Seven other miRNAs were differentially expressed in AAA tissue in two separate studies. 15 circulating miRNAs were differentially expressed in two or more separate studies. miR-155 and miR-29b were the only miRNAs differentially expressed in two separate tissue- and blood-based studies. 11 studies offered mechanistic explanations of the role of miRNAs in AAA pathology through exploration of gene targets. Three studies assessed the diagnostic potential of circulating miRNAs with receiver operating characteristic curves. Only one study assessed the prognostic potential of circulating miRNAs in predicting AAA growth. CONCLUSIONS: Several miRNAs have been found to be associated with human AAA. Their utility as AAA biomarkers requires further investigation.
BACKGROUND AND AIMS: There is increasing interest in identifying novel methods for abdominal aortic aneurysm (AAA) diagnosis. Non-coding RNA molecules such as microRNAs (miRNAs) are stable within the circulation and may serve as biomarkers for AAA. This systematic review aimed to identify miRNAs associated with a diagnosis of humanAAA based on currently published original research. METHODS: A systematic search of the MEDLINE and EMBASE databases identified studies assessing miRNA expression in abdominal aortic tissue or circulating blood from humanAAA cases compared to non-aneurysmal controls. Data from included studies were extracted to assess methods and results after independent quality assessment by two reviewers. RESULTS: 15 studies were included in this review. 11 studies obtained aortic tissue samples from 195 AAA cases and 104 controls with normal aortas. Nine studies obtained circulating blood samples from 526 AAA cases and 441 controls. miR-21 was differentially expressed in AAA tissue in five separate studies, with four studies reporting upregulation and one reporting downregulation. Seven other miRNAs were differentially expressed in AAA tissue in two separate studies. 15 circulating miRNAs were differentially expressed in two or more separate studies. miR-155 and miR-29b were the only miRNAs differentially expressed in two separate tissue- and blood-based studies. 11 studies offered mechanistic explanations of the role of miRNAs in AAA pathology through exploration of gene targets. Three studies assessed the diagnostic potential of circulating miRNAs with receiver operating characteristic curves. Only one study assessed the prognostic potential of circulating miRNAs in predicting AAA growth. CONCLUSIONS: Several miRNAs have been found to be associated with humanAAA. Their utility as AAA biomarkers requires further investigation.
Authors: Daniel P Zalewski; Karol P Ruszel; Andrzej Stępniewski; Dariusz Gałkowski; Marcin Feldo; Janusz Kocki; Anna Bogucka-Kocka Journal: J Clin Med Date: 2022-06-16 Impact factor: 4.964
Authors: Daniel P Zalewski; Karol P Ruszel; Andrzej Stępniewski; Dariusz Gałkowski; Jacek Bogucki; Łukasz Komsta; Przemysław Kołodziej; Paulina Chmiel; Tomasz Zubilewicz; Marcin Feldo; Janusz Kocki; Anna Bogucka-Kocka Journal: J Clin Med Date: 2020-06-24 Impact factor: 4.241
Authors: Emma Plana; Laura Gálvez; Pilar Medina; Silvia Navarro; Victoria Fornés-Ferrer; Joaquín Panadero; Manuel Miralles Journal: Int J Mol Sci Date: 2020-06-28 Impact factor: 5.923
Authors: Gabor Gäbel; Bernd H Northoff; Amanda Balboa; Mediha Becirovic-Agic; Marcelo Petri; Albert Busch; Lars Maegdefessel; Adrian Mahlmann; Stefan Ludwig; Daniel Teupser; Vivian de Waard; Jonathan Golledge; Anders Wanhainen; Dick Wågsäter; Lesca M Holdt; Jan H N Lindeman Journal: J Am Heart Assoc Date: 2021-08-21 Impact factor: 5.501